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Abstract:  Aptamers  have  been  widely  used  as  recognition  elements  for  biosensor 
construction, especially in the detection of proteins or small molecule targets, and regarded 
as promising alternatives for antibodies in bioassay areas. In this review, we present an 
overview of reported design strategies for the fabrication of biosensors and classify them 
into four basic modes: target-induced structure switching mode, sandwich or sandwich-like 
mode, target-induced dissociation/displacement mode and competitive replacement mode. 
In  view  of  the  unprecedented  advantages  brought  about  by  aptamers  and  smart  design 
strategies, aptamer-based biosensors are expected to be one of the most promising devices 
in bioassay related applications.  
Keywords: aptamer; biosensor; design strategy 
 
 
OPEN ACCESS Sensors 2010, 10                                       
 
 
4542 
1. Introduction 
Basically, a biosensor is a device that comprises two or more of the following parts: recognition 
component, linker, localization component, signal receptor, signal amplification component and signal 
transducer, etc. Among them, at least two parts are unavoidable: one is the recognition part, which 
could specifically recognize and identify target, and the other is the signal transduction part, which 
could transform the signal of analyte into some detectable signal. Recognition components, typically 
enzymes, antibodies or nucleic acids, directly decide the selectivity, sensitivity, stability, as well as 
application prospects of biosensors. Among them, antibodies were regarded as almost the only choice 
in  protein  detection.  Recently,  a  new  class  of  recognition  components,  aptamer,  has  attracted 
tremendous attention and been supposed to be promising alternatives of conventional recognition elements. 
Aptamers are oligonucleotides (single-stranded DNA or RNA) that can bind their targets with high 
affinity and specificity. Ever since the concept of aptamer was raised by Ellington [1] and Louis [2] 
and  the  technology  of  systematic  evolution  of  ligand  by  exponential  enrichment  (SELEX)  was 
developed for isolation of aptamers in 1991 [3], more and more aptamers have been reported, which 
could specifically bind to various target ligands cover from small ions, single molecules to proteins, 
even cells. Recently, aptamers have received tremendous attention as recognition components in the 
biosensors design and analytical and diagnostic applications. Compared with conventional recognition 
components―monoclonal antibodies, aptamers possess analogical or even better attributes [4-6]: 
a.  Aptamers show high affinity and exquisite specificity for cognate ligands as well as for some 
ligands  which  could  not  be  recognized  by  antibodies,  such  as  ions  or  small  molecules, 
indicating that employing aptamers as the recognition components may markedly broaden the 
applications of the corresponding biosensors. 
b.  Once selected, aptamers could be massively synthesized via chemical progress, which is more  
cost-effective  than  the  production  of  antibodies.  Consequently,  the  cost  for  fabrication  of  
aptamer-based biosensors could be cut down. 
c.  Aptamers  can  more  easily  be  modified  chemically  than  antibodies,  especially  for  the 
modification of signal moieties, such as electrochemical probes, fluorophores and quenchers, 
which greatly facilitates the fabrication of biosensors. 
d.  Aptamers are more robust at elevated temperatures, and thermal denaturation of aptamers is 
reversible.  While  as  proteins,  antibodies  are  more  thermally  sensitive,  and  denaturation  of 
antibodies is usually irreversible. Thus use of aptamers offers a wide range of assay conditions. 
e.  The binding of aptamers with their targets usually relies on specific conformations, such as  
G-quaduplex,  hairpin.  The  conformational  variations  before  and  after  the  formation  of  
aptamer-ligand  complexs  offer  a  great  possibility  and  feasibility  for  the  construction  of 
aptamer-based biosensors. 
f.  Owing to their oligonucleotide nature, they could interact with other DNA or RNA molecules, 
such as DNAzymes, thus fabricate versatile oligonucleotides machines for either biosensing or 
other clinical applications. 
g.  Nucleic acid aptamers can hybridize with their complementary sequences, which can be used to 
create the antidotes. Sensors 2010, 10                                       
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Due  to  the  above  advantages,  aptamers  are  regarded  as  promising alternatives  to  antibodies  in 
bioassay related fields and have been applied in bio-molecule detection, cell collection and detection [7,8], 
imaging [9], or other clinical treatments [4].  
Till now, several review works of aptamer-based biosensing have been published. Guo and Dong [10] 
presented approaches that involve nanoparticles (NPs) in electrochemical aptamer sensors together 
with other type of electrochemical sensors, such as genosensors, immunosensors. Willner et al. [11] 
discussed the design of aptamer-DNAzyme conjugates and their applications in amplified biosensing 
and logic gate operation. Lee et al. [12] reported the construction of nanoscale electrical biosensors 
using aptamers as molecular recognition elements and highlighted the advantages of aptamers over 
antibodies. Song et al. [5] exhibited an overview on the development of aptamer-based biosensors and 
bioassay methods. Strehlitz et al. [13] summarized the application of aptamers in protein detection. In 
Mok and Li’s review work [14], they introduced in detail the properties and the selection methods of 
aptamers, progress in engineering biosensors, and the prospect of chemical and biological applications. 
More recently, Sefah and co-workers [15] discussed the use of aptamers in biosensor development by 
sorting them into three general paradigms: structure-switching, enzyme-based, and aptazyme-based 
biosensors. While in this review, we try to give a systematic overview that concerns on the design 
strategies  for  the  fabrication  and  application  of  aptamer-based  biosensors.  Although  the  detection 
approaches or instruments may be different for various aptamer-based biosensors, the essences of the 
design strategies are somewhat similar. The main design strategies will be summarized, classified and 
compared with detailed examples. 
2. Strategies for the Construction of Aptamer-Based Biosensors 
As  is  well  known,  aptamers  interact  with  their  targets  and  form  special  three  dimensional 
conformations. According to the relative spatial positions of targets and aptamers in the target-aptamer 
complexes, the targets could be divided into two groups: embedded group and outside-binding group. 
The ligands belong to embedded group are usually buried within a small binding pocket formed by 
special oligonucleotides sequence of aptamers. Small molecules, such as ATP [16], cocaine [17], K
+ [18] 
and theophylline [19], are typical targets of this group. Because of the embedment of the ligands, the 
design strategies mainly concern on the manipulation of the aptamers. Biomacromolecules, typically 
protein targets, which  possess complicated spatial structures, belong to the outside-binding group. 
Some proteins, such as thrombin [20], platelet-derived growth factor-BB (PDGF-BB) [21], have more 
than one aptamer-binding site, which could offer diverse designs of sensing strategies. 
Till now, plenty of research works concerned with the fabrication of aptamer-based biosensors have 
been  reported.  These  biosensors  were  well-constructed  by  a  variety  of  methodologies,  including 
electrochemical biosensors, optical biosensors, mass-sensitive biosensors, etc. However, the design 
strategies of most of these biosensors have some versatile or analogical elements. Thus, we try to 
divide these strategies into four modes: (a) target-induced structure switching mode; (b) sandwich or 
sandwich  like  mode;  (c)  target-induced  dissociation  or  displacement  mode;  (d)  competitive 
replacement mode. 
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2.1. Target-Induced Structure Switching (TISS) Mode 
In  this  mode,  the  targets  directly  bind  to  their  aptamers,  along  with  the  corresponding 
conformational switch of aptamers to specific patterns instead of random structures, and subsequently 
lead to the changes of detectable characters, including: 
(a) The position, quantity or status of the signal moieties, which covalently bind to the end of 
aptamers or adsorbed on the aptamers via electrostatic force, stacking, hydrogen bond, etc.; 
(b)  The size or weight of aptamers, along with the formation of aptamer-target complexes; 
(c)  Other properties of aptamers, such as the ability to stabilize gold nanoparticles (AuNPs), etc. 
Each of the changes above implies a change of signals and opportunity for the design of aptamer-based 
biosensors. Such mode of design fits to both embedded group and outside-binding group. Several 
different  designs  of  TISS  mode  have  been  reported,  such  as  the  aptamer  beacon  [22,23],  
target-responsive electrochemical aptamer switch (TREAS) [24].  
Upon the binding of the targets to the aptamers immobilized on the surface of electrodes, aptamers 
switch into rigid tertiary structures, such as G-quaduplex, from random flexible conformations. Such 
conformational switches would change the relative positions of signal moieties which are covalently 
linked to the end of aptamers towards the electrodes, leading to the changes of electrochemical signals. 
Based on such TISS, several electrochemical aptamer-based biosensors have been designed. 
A  redox  probe-labeled,  signal-off  electrochemical  biosensor  was  first  developed  for  thrombin 
detection [20]. Before thrombin binding, the electrochemical active redox moiety, methylene blue (MB) 
which was labeled at the end of aptamer covalently, could transfer electron with the electrode surface 
due to the flexible conformation of the aptamer. However, once thrombin was captured by the aptamer 
and the G-quaduplex structure was formed, the MB moiety was kept away from the electrode surface, 
resulting in the electrochemical signal-off (Figure 1). Such design has a main disadvantage of negative signal. 
Figure 1. Design of a signal-off electrochemical aptamer biosensor for thrombin detection 
(adapted from reference [20], with kind permission). 
 
To overcome aforementioned disadvantage, signal-on electrochemical biosensors were developed. 
In  a  typical  work,  thrombin-binding  aptamer  immobilized  on  polycrystalline  gold  electrode  was 
covalently  attached  with  ferrocene  (Fc)  at  the  other  end  [22].  The  electrode  surface  was  further Sensors 2010, 10                                       
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blocked by 2-mercaptoethanol. No signal was obtained before the binding of thrombin, because the 
flexible  unfolded  aptamer  led  to  the  large  electron-tunneling  distance  between Fc moiety  and  the 
electrode. In the presence of thrombin, the rigid G-quaduplex structure would drag the Fc moiety to 
approach the electrode surface, and the electron transfer between the Fc and electrode was realized 
(Figure 2). The signal-on design of this biosensor produces positive signals, which apparently broaden 
the  detection  range  of  biosensors.  However,  the  flexibility  of  aptamers  immobilized  on  electrode 
surface can bring high background signals and influence the reproducibility of biosensors. 
Figure 2. Design of a signal-on electrochemical aptamer biosensor for thrombin detection 
(adapted from reference [22], with kind permission). 
 
To circumvent the problems induced from random structure of single-stranded oligonucleotides, the 
immobilized  aptamer  with  Fc  label  was  hybridized  with  its  complementary  sequence  to  form  
double-stranded DNA (dsDNA). In the absence of target, electron transfer between Fc at the end of 
aptamer and the electrode was completely blocked due to the large distance and the rigid structure of 
dsDNA. Thus the background signal could be effectively inhibited. However, in the presence of target, 
the complementary sequence was liberated and the aptamer switched to hairpin structure and bound 
with the target, which greatly shortened the distance between Fc and the electrode and subsequently 
turned on the electron transfer path. This biosensing strategy was named TREAS [24]. In this case, the 
design  of  the  complementary  sequence  of  the  aptamer  is  important.  The  dissociation  constant  of 
aptamer and its complementary sequence, together with the dissociation constant of aptamer and its 
target would markedly influence the performance of biosensors. 
Similar  research  has  also  been  published.  The  fabricated  biosensors  have  been  used  for  the 
detection of thrombin [23,25], theophylline [19], PDGF [26,27], cocaine [28,29], not only for standard 
samples, but also in clinical samples [24,26]. 
Besides  electrochemical  biosensors,  TISS  strategy  could  utilize  to  design  other  classes  of 
biosensors. Aptamer-based molecule beacon fluorescent detection is another frequently utilized way 
for biosensor design. In aptamer beacons, fluorophores which can provide report signals and quenchers 
which  can  quench  fluorescent  signals  are  covalently  linked  to  the  ends  of  aptamers  or  the 
complementary sequences of aptamers. The relative position of fluorophores and quenchers, which 
decides the intensity of fluorescent signal, is related with the presence of the target, and subsequently 
the  conformation  of  aptamer.  For  instance,  guanine  bases  were  used  as  quencher  to  develop  two Sensors 2010, 10                                       
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different cost-effective and label free aptamer-based sensors, named hairpin design and duplex design [30]. 
In the absence of target thrombin, the aptamer sequence formed a hairpin structure by itself in the 
hairpin design (Figure 3A) or double-stranded status with a complementary sequence in the duplex 
design (Figure 3B). The 5’-end fluorescent signal moiety was quenched by the guanine bases at the 3’-end 
of the aptamer or the 3’-end of complementary sequence, hence, quenching structures were formed and 
no  fluorescent  signal  could  be  detected.  However,  in  the  presence  of  thrombin,  the  formation  of  
target-aptamer complex would destruct the quenching structure and separate the fluorophore from the 
guanine bases, thus restore fluorescence signal. In another research, pyrene monomers were labeled 
with each end of the aptamer of PDGF. While the target existed, the fluorescence emission of the 
labeled aptamer switched from 400 nm to 485 nm, due to the conformational rearrangement of aptamer 
induced by target binding. The established method has been proven to be effective in direct detection 
and quantification of PDGF in complex biological samples [31]. 
Figure 3. Schemes for the target-induced structure switching aptamer beacons. (A) Hairpin 
design and (B) duplex design (adapted from reference [30], with kind permission). 
 
Colorimetric assays are another popular optical detection technique. In recent years, AuNPs have 
been widely used in optical biosensor design, due to their characteristic spectroscopic changes during  
target-induced aggregation or dispersion. Researchers showed that adsorption of single-stranded DNA 
(ssDNA) on AuNPs can effectively stabilize the colloid against salt-induced aggregation while dsDNA 
has no such function [32,33]. Then colorimetric aptamer-based biosensors were developed [34]. While 
the target ATP was absent, the aptamer hybridized with its complementary sequence to form a rigid 
duplex, which could not prevent AuNPs from aggregating as salt added into the system. However, as 
ATP  was  present,  the  duplex  structure  would  switch  to  ATP-aptamer  complex  together  with  the 
release of its complementary sequence, which could stabilize AuNPs and show high resistance to  
salt-induced  aggregation  (Figure  4).  The  changes  of  solution  color  caused  by  AuNPs  aggregation 
could easily observed by naked eyes. And the corresponding changes in UV-visible spectra could be 
used to quantitative assay of ATP. Similarly, another research indicated that the AuNPs modified by  
target-binding folded aptamer showed higher stability toward salt-induced aggregation than the AuNPs 
modified with unbinding aptamer. And a colorimetric biosensor was developed for the assay of ATP or 
K
+,  according  to  this  target-induced  structure  switching  of  the  aptamer  modified  on  the  surface  
of AuNPs [18]. Sensors 2010, 10                                       
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Figure  4.  Scheme  for  the  target-induced  structure  switching  and  salt-induced  AuNPs 
aggregation (adapted from reference [34], with kind permission). 
 
Besides  the  electrochemical  and  optical  biosensors  mentioned  above,  mass-sensitive  biosensors 
could also be fabricated via TISS strategy, which detect target-induced changes in size or mass of 
aptamers. Frequently used mass-sensitive techniques include surface plasmon resonance (SPR) [35], 
quartz  crystal  microbalance  (QCM)  [36]  and  surface  acoustic  wave  device  (SAW)  [37],  etc.  In  an 
aptamer-based AuNPs-enhanced SPR detection, AuNPs, the SPR signal enhancer, was immobilized 
via DNA hybridization with the aptamer sequence. Like the TREAS strategy mentioned above, the 
binding of ATP led to formation of tertiary structure and dehybridization between aptamer and the 
AuNPs tagged complementary ssDNA, which finally resulted in the decrease of the SPR signal [35]. 
2.2. Sandwich or Sandwich-Like Mode 
As named, the sandwich mode devices consist of at least three parts, “a piece of meat” inserted 
within  “two  pieces  of  bread”.  Some  protein  targets,  such  as  PDGF-BB  and  thrombin,  have  dual 
binding sites, which endows them the ability to bind two recognition molecules and form sandwich-like 
complexes. Since these proteins could specifically bind either aptamers or antibodies, the sandwich 
structures  have  three  basic  formats:  aptamer-protein-aptamer,  aptamer-protein-antibody  and  
antibody-protein-antibody.  The  first  two  formats  have  been  widely  employed  in  design  of  
aptamer-based biosensors. 
An electrochemical  biosensor for PDGF detection via sandwich structure and AuNPs mediated 
amplification has been constructed [21]. As shown in Figure 5, the aptamer was immobilized on the 
electrode surface through self-assembly. In the presence of the target PDGF-BB, it would be captured 
onto  the  interface  through  the  formation  of  PDGF-aptamer  complex.  Then  the  aptamer  modified 
AuNPs, which are negative charged, recognized the target specifically and bound to the electrode 
surface to form a sandwich structure. Finally, the positive charged [Ru(NH3)5Cl]
2+, used as probe, was 
adsorbed to the sandwich structure via electrostatic interaction. The obtained electrochemical signals 
were directly concerned with the concentration of PDGF.  
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Figure  5.  Scheme  for  the  formation  of  sandwich  structure  and  Au-NPs  mediated 
amplification for PDGF detection (adapted from reference [21], with kind permission). 
 
Similarly, sandwich mode has been reported for the high specific detection of thrombin through 
construction  of  aptamer-protein-aptamer  structure  in  the  electrochemiluminescence  (ECL)  sensor 
design [38], the magnetic beads coupled  assay  [39] and  the impedimetric  assay [40]. Meanwhile, 
antibodies  were  also  employed  for  the  recognition  of  target,  together  with  aptamer  for the signal 
carrier, to detect thrombin through the formation of aptamer-protein-antibody structure [41,42]. 
Since the sandwich design requires dual binding sites of targets, it can hardly be applied to the 
assay of embedded groups of targets. However, another type of sandwich-like mode can be adapted to 
their detection, which involves the manipulation and design of the aptamers and their complementary 
sequences.  For  instance,  in  an  adenosine  biosensor  design  [43],  a  thiolated  capture  probe  was 
immobilized onto the AuNPs modified gold electrode. Then a linker DNA containing antiadenosine 
aptamer  sequence  and  reporter  DNA  loaded  on  AuNPs  was  bound  to  the  electrode  through 
hybridization. [Ru(NH3)6]
3+ was adsorbed to DNA molecules via electrostatic interaction and used to 
produce electrochemical signal. In the presence of adenosine, the aptamer part of the linker DNA 
bound with adenosine to form target-aptamer complex structure, resulting in the release of reporter 
probes  modified  AuNPs  together  with  [Ru(NH3)6]
3+,  which  subsequently  led  to  the  decrease  in 
electrochemical  signal  (Figure  6).  Based  on  similar  mechanism,  an  ATP  biosensor  fabricated  via 
fluorescence  resonance  energy  transfer  (FRET)  between  a  quantum  dot  as  donor  and  an  organic 
fluorophore as acceptor has also been reported [44]. 
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Figure 6. Scheme for sandwich-like structure for the detection of adenosine (adapted from 
reference [43], with kind permission). 
 
2.3. Target-Induced Dissociation/Displacement (TID) Mode 
Both the TISS mode and the sandwich mode belong to structure-dependent assay. The fabrication 
of those aptamer-based biosensors is highly relying on the special conformations of the aptamers (such 
as G-quaduplex or hairpin conformation), or the specific target-aptamer complex structures. However, 
in the design of some biosensors, especially for the electrochemical aptamer-based biosensors, a TID 
mode, which belongs to a structure-independent strategy, has been raised [16]. 
In  TID  mode,  the  complementary  sequences  of  aptamers,  instead  of  aptamers  themselves,  are 
employed as anchors to localize the aptamers. After incubation with targets, the formed target-aptamer 
complexes will be liberated into the solution, which leads to the changes of detectable signals. TID 
strategy can be further classified into signal-off mode [45-47], signal-on mode [16,48] and label-free 
mode [49,50], as shown in Figure 7.  
In signal-off mode, the presence of targets can be determined from the signal suppression due to the 
release of redox-tagged aptamer from the electrode into solution. As an example, signal-off design for 
ATP and thrombin assay [45], the redox-tag attached aptamers was confined near the electrode surface 
through the hybridization with their thiolated complementary sequence, which was self-assembled on 
the gold electrode. In the absence of targets, the redox-tag gave electrochemical signals. While targets 
were added, the redox-tagged aptamers were released and the electrochemical signals were greatly 
reduced (Figure 7A). Then signal-on mode TID strategy has also be developed. In the construction of 
an  ATP  biosensor  [16],  the  aptamer  hybridized  with  its  thiolated  complementary  sequence  was 
immobilized on the gold electrode via Au-S bond. As the target ATP was added, the aptamer sequence Sensors 2010, 10                                       
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was released from double strands to form target-aptamer complex. The the remained complementary 
sequence was further hybridized with another Fc-moiety modified ssDNA, resulting in the emergence 
of electrochemical signal (Figure 7B). Further, label-free TID strategy was also proposed. In a faradic 
impedance spectroscopy (FIS) for lysozyme assay [50], the release of the aptamer due to the formation 
of  target-aptamer  complex  would  decrease  the  interfacial  electron  transfer  resistance,  which  was 
utilized to quantify the concentration of lysozyme (Figure 7C). 
Figure  7.  Schemes  for  the  target-induced  dissociation/displacement  strategies.  
A. signal off mode [45]; B signal-on mode [16]; C label-free mode [50]. 
 
Besides electrochemical biosensors, the TID mode has also been widely employed in other types of 
aptamer-based  biosensors.  For  example,  in  an  adenosine  detection  method,  the  target  induced  the 
dissociation of aptamer from its complementary signal sequence, which could be captured later and 
characterized  via  surface-enhanced  Raman  scattering  method  [51].  Similarly,  a  surface  enhanced 
resonance Raman scattering (SERRS) biosensor for thrombin detection has also been fabricated [52]. 
For colorimetric assay, the presence of adenosine induced the dissociation of aptamer from dsDNA 
modified  AuNPs  and  the  remained  ssDNA  modified  AuNPs  would  aggregate,  which  could  be 
observed by the naked eye [53].  
2.4. Competitive Replacement Mode 
As aptamers share similar characteristics with antibodies, various detection methods which take 
advantage  of  antibodies  can  be  developed  into  aptamer-based  methods.  For  instance,  most 
immunoassays  for  small  molecules  are  competitive  assays  relying  on  the  replacement  of  
surface-bound antibodies by the analyte in solution. This replacement mode could be applied to the 
aptamer-based assays. Hence a new type of strategies, named as competitive replacement mode, has 
been developed. In this mode, signal modified target molecules need to be designed and synthesized  
in advance. Sensors 2010, 10                                       
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As early as in 2000, a fiber-optic microarray biosensor using aptamers as receptors was developed [54], 
which was complementary to the conventional ELISA technique. In this research, the aptamer bead on 
the  fiber  surface  was  incubated  with  the  fluorescence-labeled  thrombin  (F-thrombin).  As  the  
non-labeled target thrombin was added, it would competitively bind to the aptamer bead and replace 
the F-thrombin, which led to the decrease of fluorescent signal. Hence, non-labeled thrombin could be 
detected. In recent years, nanoparticles, especially quantum-dots (QDs) have been employed to label 
proteins. As shown in Figure 8, an ultra-sensitive electrochemical biosensor has been developed for 
the detection of thrombin and lysozyme simultaneously [55]. The thiolated aptamers of thrombin and 
lysozyme were co-immobilized onto the gold substrate, followed with the binding of CdS-labeled 
thrombin  and  PdS-labeled  lysozyme  through  the  formation  of  labeled  protein-aptamer  complexes 
respectively.  As  the  sample  containing  detection  targets  was  added,  the  label-proteins  could  be 
displaced by targets, which could be characterized through electrochemical stripping detection. 
Figure  8.  Dual-analyte  biosensor  designed  via  the  competitive  replacement  mode  and 
electrochemical stripping detection (adapted from reference [55], with kind permission). 
 
Recently, the competitive replacement mode has been applied to the detection of the small molecule 
neomycin B in milk via the FIS [56] and SPR [57] approaches. Neomycin B was immobilized on a  
self-assembled  monolayer  (SAM)  of  mercaptopropionic  acid  on  a  substrate  surface  through 
carbodiimide chemistry. Then, the aptamer was attached to the neomycin B via binding affinity. The 
presence of neomycin B in sample would competitively bind to the aptamer modified on the surface, 
leading to changes in surface modification, which could then be detected via FIS or SPR. 
Carbon nanotubes (CNTs) have widely attracted substantial research interests due to their special 
structural  features  and  unique  electronic  properties,  and  have  also  been  applied  in  aptamer-based 
biosensing.  For  example,  single-walled  carbon  nanotubes  (SWCNTs),  with  the  ability  to  quench 
covalently tethered and/or π-stacked pyrenes, porphyrins and chromophores [58], have been used to 
establish a sensing platform in which the targets could competitively bind to the dye-labeled aptamer. 
As a result, SWCNTs were substituted and the quenching effect was eliminated. Thus, the recovered 
fluorescence signal of the dye molecules could be used to detect targets [59]. 
2.5. Aptamer-Based DNA/RNA Machine in Biosensor Design 
2.5.1. Aptamer-aptamer combination 
An aptameric enzyme subunit (AES) is a DNA aptamer composed of an enzyme-inhibiting aptamer 
and a target-binding aptamer. It can allosterically regulate the corresponding enzymatic activity upon 
binding to the target molecule, which means, measuring the corresponding enzymatic activity could Sensors 2010, 10                                       
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indirectly determine the target molecule in a homogeneous solution. AESs were originally designed for 
detection  of  insulin  [60],  IgE  [61]  and  adenosine  [62]  by  connecting  the  target-binding  aptamer 
sequences with the splinted thrombin-inhibiting aptamer. In this kind of protocol, the target molecules 
competitively bound to thrombin binding AESs. As a result, the AESs’ conformation changed and the 
allosteric  regulation led  to  the dissociation  of thrombin  from the AES-thrombin  complex into the 
solution. Using AESs, the detection of targets were realized by measuring thrombin enzymatic activity 
in  the  solution,  which  enabled  simple  and  high-sensitive  detection  of  target  molecules  in  a 
homogeneous assay. 
2.5.2. Aptazyme 
The discovery of RNAzyme and DNAzyme unraveled the innate potential of oligonucleotides in 
many  biological  applications  other  than  as  the  storage  media  of  genetic  information  [15]. 
DNAzyme/RNAzyme,  as  two  classes  of  nucleic  acids  which  have  catalytic  activities  and  special 
functions in biological research, have also attracted great attention for their analytical and various 
other applications [63]. The nature of nucleic acids endows aptamer and DNAzyme/RNAzyme native 
ability to cooperate with each other. For example, anti-hemin aptamer shows peroxidase activity when 
hemin  is  captured  and  the  G-quaduplex  structure  is  formed.  Such  DNAzyme  could  catalyze  the 
oxidation of 2,2’-azino-bis(3-ethylbenzothiazoline- 6-sulfonic acid), ABTS
2-, by H2O2 to the ABTS
－•  
colored product or stimulate the generation of chemiluminescence in the presence of H2O2/luminol [64]. 
An optical biosensor for the determination of adenosine has also been constructed via rational design. 
In the presence of adenosine, the anti-adenosine sequence formed a rigid structure with its ligand. The 
rigid  structure  produced  a  spatial  hindrance  and  inhibited  the  formation  of  hemin-contained 
DNAzyme. However, the absence of adenosine would lead to the formation of DNAzyme which gave 
detectable  signal  [63].  Similar  work  was  reported  for  the  detection  of  lysozyme  [64].  In  another 
colorimetric design, by combination of anti-adenosine aptamer with DNAzyme with phosphodiester 
cleavage activity, the presence of adenosine could be characterized through the dispersal of aggregated 
AuNPs linked by the substrate strand of DNAzyme, which was inactive in the absence of adenosine 
[65]. 
3. Conclusions 
Owing to their excellent characteristics, aptamers have been regarded as one of the most promising 
recognition elements in biosensor fabrication, especially in proteins or small molecules assays. An 
overview of the design strategies for the fabrication of aptamer-based biosensors has been presented in 
this review. Regardless of the kinds of targets or transducers, most reported aptamer-based biosensors 
can  be  classified  into  four  basic  modes:  target-induced  structure  switching  mode,  sandwich  or 
sandwich-like  mode,  target-induced  dissociation/displacement  mode  and  competitive  replacement 
mode, which represent the dominating design strategies of such type of devices at present. Besides, 
several new strategies have arisen from the combination of aptamer with other functional nucleic acids, 
such as aptamer or the DNAzyme/RNAzyme. 
Generally, these design strategies target turning the specific binding process between ligands and 
aptamer into different signal variations so that ligands could be effectively detected. All designed Sensors 2010, 10                                       
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biosensors have excellent performance in the detection of standard samples. However, only a few of 
them have been applied in detection of real samples, such as serum or blood. Among them, TID mode 
shows  less  dependence  on  the  conformation  of  the  ligands  or  aptamers  thus  is  more  generalized 
compared to other strategies. There remains plenty of work to be done in this stage before aptamer-based 
biosensors  could  be  practically  applied,  including  improvements  of  their  stability  and  reliability, 
especially in real sample detection. 
On the other hand, only a small range of targets have presently been detected using aptamer-based 
biosensors. The extensive development of these biosensors needs to further screen and characterize the 
specific aptamer sequences of different targets. Nevertheless, an aptamer database has been created to 
contain comprehensive sequence information on aptamers and other functional nucleic acids generated 
by  in  vitro  selection.  The  database  is  updated  monthly  and  is  publicly  available  at 
http://aptamer.icmb.utexas.edu/ [66]. As the quantity of reported aptamer sequences increases, more 
and more aptamer-based biosensors with excellent performances will be fabricated via smart designing 
strategies, which will endow them great opportunity to be applied in the fields of bioassay, biomedical 
diagnostic or environmental monitoring. 
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